Investor Relations Home 
Corporate Profile

From the beginning, Rochester Medical has been focused on one thing: improving lives through more advanced and reliable urology products. Our singular focus on managing incontinence and bladder drainage has significantly improved the options available to clinicians and patients alike, and has brought us to the forefront of urinary catheter design. From state-of-the-art manufacturing facilities in the United States, we supply latex-free and phthalate-free products to customers in more than 70 countries. Our advanced product line features male external catheters, intermittent catheters, Foley catheters and urethral inserts, as well as latex-free catheter accessories.

Proxy Materials
Download Documentation2012 Proxy Statement
Download Documentation2012 Annual Report
Download Documentation11/20 Investor Presentation

ROCM (common stock)
Last TradeChange% ChangeVolume
$20.00 + 0.020.10%21,100
Exchange: NONE (US Dollar)
11/13/13 4:00 p.m. ET
Minimum 20 Minute Delay
Refresh quote
Recent News
10/10/13Rochester Medical To Hold Special Meeting Of Shareholders November 13, 2013 To Approve Definitive Agreement To Be Acquired By C.R. BardPrinter Friendly Version
09/04/13Rochester Medical to be Acquired by C. R. Bard for Approximately $262 MillionPrinter Friendly Version
07/30/13Rochester Medical Reports Fiscal 2013 Third Quarter ResultsPrinter Friendly Version
Shareholder Information
Primary IR Contact
Investor Relations
Rochester Medical
Tel: 507-533-9600
Tel: 800-615-2364
Fax: 507-533-9725
Transfer Agent
Wells Fargo Shareowner Services
Wells Fargo Bank Minnesota, N.A.
Post Office Box 64854
St. Paul, MN 55164-0854
Tel: 1-800-468-9716

Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.